About
Cardiovascular Systems, Inc. (CSI) is a medical device company based in St. Paul, Minnesota, that focuses on developing and commercializing products for treating peripheral and coronary vascular diseases. As a subsidiary of Abbott Laboratories, CSI specializes in orbital atherectomy systems, which are minimally invasive devices designed to address atherosclerotic plaque buildup in arteries. The company's product lineup includes Peripheral Orbital Atherectomy Systems, such as the Diamondback 360® and Stealth 360®, as well as Coronary Orbital Atherectomy Systems. These devices aim to improve blood flow by removing or modifying plaque and are intended to complement standard treatments like balloon angioplasty and stenting. CSI also offers a range of crowns and accessories to support atherectomy procedures. The company markets its products through a network of distributors to hospitals and clinics across the United States, serving healthcare providers and patients with peripheral arterial disease and coronary artery disease.
Technologies
Keywords
Company Information
-
Employees 730
-
Founded 1989
-
Annual Revenue $236222000
-
Total Funding $141290116
Location
1225 Old Highway 8 Northwest, Saint Paul, Minnesota, United States, 55112